BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,752,940 | +4709.5% | 836,760 | +4548.7% | 0.01% | +900.0% |
| Q1 2023 | $57,240 | -85.7% | 18,000 | -71.6% | 0.00% | -87.5% |
| Q3 2022 | $401,000 | -36.2% | 63,296 | -51.2% | 0.01% | -52.9% |
| Q1 2022 | $629,000 | +522.8% | 129,729 | +1185.6% | 0.02% | +466.7% |
| Q4 2021 | $101,000 | -86.2% | 10,091 | -73.6% | 0.00% | -85.7% |
| Q3 2021 | $731,000 | +168.8% | 38,247 | +350.4% | 0.02% | +133.3% |
| Q2 2021 | $272,000 | -40.4% | 8,492 | +63.3% | 0.01% | -69.0% |
| Q4 2019 | $456,000 | -84.9% | 5,200 | -84.2% | 0.03% | -83.9% |
| Q3 2019 | $3,019,000 | +208.4% | 32,867 | +326.8% | 0.18% | +68.2% |
| Q2 2019 | $979,000 | -49.8% | 7,700 | -37.9% | 0.11% | -66.7% |
| Q1 2019 | $1,951,000 | – | 12,400 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
| qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
| Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
| Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
| Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
| HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
| Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
| PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
| Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
| Summit X, LLC | 103,424 | $651,000 | 0.19% |